相关实验视频

Updated: Jan 12, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

[HPV整合测试在HPV阳性女性的分拣管理中的潜在价值]

J J Li¹, W Y Guan², C Z Chu³

¹Department of Precision Medicine, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing 210008, China.

Zhonghua fu chan ke za zhi

|October 30, 2025

概括

人类乳头瘤病毒 (HPV) 基因组集成在宫病变中很常见,并且与癌症进展有关. 检测宫细胞中的HPV融合可以改善查和患者管理.

科学领域:

在瘤学瘤学.
病毒学病毒学
遗传学是一个遗传学.

背景情况:

子宫癌主要是由持续高风险的人类乳头瘤病毒 (HR-HPV) 感染引起的.
将HPV DNA集成到宿主基因组是宫癌发生的关键步骤.
了解HPV整合动态对于改善宫癌查和管理至关重要.

研究的目的:

调查宫病变进展期间HPV基因组整合的动态特征.
评估HPV整合检测在分层HPV阳性女性中的临床价值.
探索HPV集成在宫癌发生的分子机制.

主要方法:

一项前性队列研究涉及157名HR-HPV阳性女性,她们有不同程度的宫病变.
使用HPV全基因组向捕获和高通量测序分析了宫脱皮细胞.
对HPV整合模式,宿主基因分布和途径丰富的分析.

主要成果:

在80.2%的样本中检测到HR-HPV集成,宫癌的发病率更高.
在高度病变 (CIN III和宫癌) 中,HPV16集成的频率明显高.
整合地点主要位于基因间和内基因区域,影响诸如cGMP-PKG信号传导之类的通路.

结论:

HPV 整合事件与子宫病变的进展有显著的关联.
在宫脱皮细胞中检测HPV融合可以优化查策略.
这种方法可以减少不必要的干预,并促进HPV阳性女性的准确分拣.

更多相关视频

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

相关概念视频

Sensitivity, Specificity, and Predicted Value

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...